# To Validate an Analytical Method to Measure Concentration of Tacrolimus in Blood Taken From Finger Pricks

> **NCT02377609** · — · TERMINATED · sponsor: **Astellas Pharma Europe Ltd.** · enrollment: 108 (actual)

## Conditions studied

- Validation
- Dried Blood Spot
- Transplant Patients

## Interventions

- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT02377609
- **Lead sponsor:** Astellas Pharma Europe Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2013-10
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 108 (ACTUAL)
- **Why stopped:** DBS method not be validated against the standard of care venepuncture method due to quality of blood sample and variable tacrolimus extraction
- **Last updated:** 2015-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02377609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02377609, "To Validate an Analytical Method to Measure Concentration of Tacrolimus in Blood Taken From Finger Pricks". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02377609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*